Dallah Healthcare Company

Equities

4004

SA135G51UI10

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. Other stock markets 03:30:00 29/04/2024 am IST			5-day change	1st Jan Change
162.6 ^SAR	-0.25%		-3.33%	-5.36%

20/03	Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
14/03	Dallah Healthcare Logs Higher FY23 Net Profit, Revenue	MT

Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee

November 16, 2022 at 09:33 am IST

Dallah Healthcare Company announced that its board of directors has approved the resignation of the board member, Dr. Fahad bin Abdulaziz Al-Rabiah, from the membership of the board of directors and compensation and remuneration committee, effective from November 15, 2022 due to his personal reasons.

Latest news about Dallah Healthcare Company

Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Dallah Healthcare Logs Higher FY23 Net Profit, Revenue	14/03	MT
Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare	05/03	MT
Dallah Healthcare Company signed of a non-binding memorandum agreement to acquire 97% stake in Al-Ahsa Medical Services Company and 100% stake in Al-Salam Medical Services Company from Ayyan Investment Company.	26/02	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for the Fourth Quarter of 2023, Payable on 30 January 2024	26/12	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/23/13	CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Dallah Healthcare Company completed the acquisition of an additional 18.98% stake in International Medical Centre.	16/23/16	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for Second Half of the Fiscal Year 2022, Payable on December 29, 2022	19/22/19	CI
Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee	16/22/16	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/22/10	CI
Dallah Healthcare Company Approves Board Appointments	02/22/02	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2022	21/22/21	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/22/18	CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2022	19/22/19	CI
Dallah Healthcare Company Receives Ministry of Health's Approval to Increase the Operational Capacity of Dallah Namar Hospital by 150 Additional Beds	24/22/24	CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Dallah Healthcare Company signed of a non-binding memorandum of understanding to acquire an additional 18.98% stake in International Medical Centre.	25/22/25	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter Ended September 30, 2021	08/21/08	CI
Dallah Healthcare Company signed an agreement to acquire a 8.2% stake in International Medical Centre from Abdulaziz Mohammed Al Meshaal and Abeer Mohammed Al Meashaal for approximately SAR 290 million.	27/21/27	CI
Dallah Healthcare to Seek Acquisition	24/21/24	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2021	22/21/22	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	11/21/11	CI

Chart Dallah Healthcare Company

Duration

Period

More charts

Company Profile

Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitalsâ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicinesâ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Officeâs segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.

Sector

Healthcare Facilities & Services

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Dallah Healthcare Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

162.6 SAR

Average target price

154.4 SAR

Spread / Average Target

-5.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
DALLAH HEALTHCARE COMPANY	-5.36%	4.24B
AIER EYE HOSPITAL GROUP CO., LTD.	-17.07%	16.85B
BANGKOK DUSIT MEDICAL SERVICES	+3.60%	12.34B
IHH HEALTHCARE	+5.64%	11.77B
APOLLO HOSPITALS ENTERPRISE LIMITED	+5.24%	10.28B
ENCOMPASS HEALTH CORPORATION	+25.36%	8.38B
RAMSAY HEALTH CARE LIMITED	-0.63%	7.88B
MOUWASAT MEDICAL SERVICES COMPANY	+22.18%	7.29B
THE ENSIGN GROUP, INC.	+5.77%	6.75B
GLOBAL HEALTH LIMITED	+52.00%	4.69B

Hospitals, Clinics & Primary Care Services